Reverse transcriptase inhibitors as a novel therapeutic approach for neurological autoimmune disorders

  • Post author:
  • Post category:

Research Objective We found that approved anti-retroviral drugs could stop inflammation and block neurodegeneration. We propose to validate the re-purpose efficacy of these clinically-approved retroviral drugs. Impact We have identified…

Continue ReadingReverse transcriptase inhibitors as a novel therapeutic approach for neurological autoimmune disorders

Blood Brain Barrier (BBB)-on-Chip: Development and validation of a novel iPS-based microfluidic model of the human BBB

  • Post author:
  • Post category:

Research Objective to develop and systematically characterize a novel model of the human BBB using a microfluidic device (chip) and cells derived from induced pluripotent stem cells (iPSCs). Impact The…

Continue ReadingBlood Brain Barrier (BBB)-on-Chip: Development and validation of a novel iPS-based microfluidic model of the human BBB

Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy.

  • Post author:
  • Post category:

Translational Candidate Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy. Area of Impact Non-destructive treatment option for drug-resistant focal epilepsy…

Continue ReadingDevelopment of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy.